Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1450 of 2529 entries
View as:

A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years

Phase: N/A Priority: Normal
NCT ID: NCT00909961 Org: User:
Start: 11/30/09 End: 12/16/11 Due: 12/16/12

A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05658003 Org: User:
Start: 05/05/23 End: 01/13/27 Due: 01/13/28

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04889430 Org: User:
Start: 01/17/22 End: 03/29/29 Due: 03/29/30

Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.

Phase: N/A Priority: Normal
NCT ID: NCT02624557 Org: User:
Start: 12/21/15 End: 10/01/17 Due: 10/01/18

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00154388 Org: User:
Start: 02/28/01 End: 01/31/07 Due: 01/31/08

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Phase: N/A Priority: Normal
NCT ID: NCT04005352 Org: User:
Start: 09/25/19 End: 09/09/22 Due: 09/09/23

CAEB071 Thorough QTc Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01594255 Org: User:
Start: 07/31/09 End: - Due: -

To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT04058067 Org: User:
Start: 08/23/19 End: 01/31/23 Due: 01/31/24

Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01543854 Org: User:
Start: 03/31/12 End: 01/31/13 Due: 01/31/14

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

Phase: N/A Priority: Normal
NCT ID: NCT05201066 Org: User:
Start: 02/13/23 End: 02/14/28 Due: 02/14/29

Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications

Phase: N/A Priority: Normal
NCT ID: NCT01518101 Org: User:
Start: 01/31/12 End: 10/31/12 Due: 10/31/13

A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06376253 Org: User:
Start: 09/08/24 End: 08/30/30 Due: 08/30/31

Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT01119937 Org: User:
Start: 05/31/10 End: - Due: -

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Phase: N/A Priority: Normal
NCT ID: NCT04174157 Org: User:
Start: 09/25/18 End: 06/30/38 Due: 06/30/39

Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04558918 Org: User:
Start: 01/25/21 End: 03/06/23 Due: 03/06/24

Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01772797 Org: User:
Start: 06/30/13 End: 01/31/16 Due: 01/31/17

A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02422589 Org: User:
Start: 10/23/15 End: 12/12/17 Due: 12/12/18

Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)

Phase: N/A Priority: Normal
NCT ID: NCT03297294 Org: User:
Start: 03/14/18 End: 03/25/19 Due: 03/25/20

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00171340 Org: User:
Start: 05/31/03 End: 02/28/10 Due: 02/28/11

Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01930175 Org: User:
Start: 12/18/13 End: 09/25/19 Due: 09/25/20

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

Phase: N/A Priority: Normal
NCT ID: NCT04657822 Org: User:
Start: 06/10/21 End: 06/10/31 Due: 06/10/32

Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02758548 Org: User:
Start: 03/31/16 End: 05/31/16 Due: 05/31/17

Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan

Phase: N/A Priority: Normal
NCT ID: NCT01876368 Org: User:
Start: 09/30/13 End: 08/31/14 Due: 08/31/15

Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00739973 Org: User:
Start: 09/30/08 End: 05/31/09 Due: 05/31/10

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02792218 Org: User:
Start: 09/20/16 End: 07/20/20 Due: 07/20/21